Dr Dan Frampton is the senior bioinformatician based in the Division of Infection and Immunity, UCL (University College London), UK. He is currently working with Professor Rachel McKendry at the London Centre for Nanotechnology on the design of a rapid diagnostic test for drug resistance in tuberculosis.
His previous role was Senior Bioinformatician on the ICONIC and PANGEA projects (funded by the Wellcome Trust and the Bill & Melinda Gates Foundation, respectively), where he designed and implemented an automated pipeline to assemble viral genomes and identify drug resistance mutations from Next Generation Sequencing (NGS) data for ~20,000 clinical samples. He was responsible for investigating potential clinical linkages between patients in several influenza outbreaks, evaluating and advising on subsequent infection control measures. Whilst developing analytical methods, Dr Frampton also established a local workflow for storing and updating NGS data for high-throughput genomic studies.